United States securities and exchange commission logo

                         August 10, 2022

       Shelley Thunen
       Chief Financial Officer
       RxSight, Inc.
       100 Columbia
       Aliso Viejo, California 92656

                                                        Re: RxSight, Inc.
Statement on Form S-3
                                                            Filed August 8,
                                                            File No. 333-266651

       Dear Ms. Thunen:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Conlon
Danberg at 202-551-4466 with any questions.


                         Division of Corporation Finance

                         Office of Life Sciences
       cc:                                              Robert L. Wernli, Jr.,